Filing Details

Accession Number:
0001104659-21-146000
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-02 18:33:04
Reporting Period:
2021-11-30
Accepted Time:
2021-12-02 18:33:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1661460 Poseida Therapeutics Inc. PSTX Biological Products, (No Disgnostic Substances) (2836) 472846548
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1685138 Ltd Holdings Sciences Life Malin The Lennox Building
50 Richmond Street South
Dublin, Ireland L2 D02 FK02
No No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-30 28,592 $6.85 9,661,184 No 4 P Direct
Common Stock Acquisiton 2021-12-01 18,365 $6.85 9,679,549 No 4 P Direct
Common Stock Acquisiton 2021-12-02 4,296 $6.88 9,683,845 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The reported prices in Column 4 are weighted average prices. Those shares were purchased in multiple transactions at per share prices ranging from $6.70 to $6.95 on 11/30/2021; $6.80 to $6.90 on 12/01/2021; and $6.82 to $6.90 on 12/02/2021. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.